Medicure (MCUJF) Cash from Operations Growth (1y) (2011 - 2026)
Medicure (MCUJF) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | -391.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -391.09% |
| Jun 30, 2025 | -2,298.67% |
| Mar 31, 2025 | 566.70% |
| Dec 31, 2024 | 142.75% |
| Sep 30, 2024 | -296.04% |
| Jun 30, 2024 | -104.97% |
| Mar 31, 2024 | -176.55% |
| Sep 30, 2023 | -71.74% |
| Jun 30, 2023 | -61.18% |
| Mar 31, 2023 | 122.02% |
| Sep 30, 2022 | 12.82% |
| Jun 30, 2022 | 205.24% |
| Mar 31, 2022 | -428.31% |
| Dec 31, 2021 | 288.76% |
| Sep 30, 2021 | 62.22% |
| Jun 30, 2021 | 153.21% |
| Mar 31, 2021 | 128.87% |
| Dec 31, 2020 | 68.21% |
| Sep 30, 2020 | 119.77% |
| Jun 30, 2020 | 82.13% |